| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $299.5M | +10.1% |
| Cost of Revenue | $165.0M | +18.7% |
| Gross Profit | $134.5M | +1.2% |
| R&D Expense | $222.6M | +17.5% |
| SG&A Expense | $116.0M | +19.1% |
| Operating Income | -$324.0M | -27.5% |
| Pre-tax Income | -$314.4M | -42.3% |
| Income Tax | -$2.8M | +20.3% |
| Net Income | -$311.7M | -43.3% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $386.8M | -30.1% |
| Accounts Receivable | $1.9M | -43.9% |
| Inventory | $10.2M | -5.0% |
| Current Assets | $425.0M | -29.4% |
| Total Assets | $942.6M | -18.2% |
| Current Liabilities | $149.4M | -2.5% |
| Total Liabilities | $228.7M | -3.3% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$165.4M | +0.9% |
| Capital Expenditures | $4.0M | +2.0% |
| Investing Cash Flow | -$11.3M | +89.5% |
| Financing Cash Flow | $9.8M | -98.2% |
| Free Cash Flow | -$169.4M | +0.8% |
| Stockholders' Equity |
| $713.9M |
| -22.0% |